Barclays Adjusts Medtronic (MDT) Forecast After Encouraging Earnings Report

Wall Street Takes Note: Barclays Ups Medtronic Price Target on Blockbuster Quarter Medtronic, the global medical device giant, is finding renewed confidence among Wall Street’s top analysts after delivering a strong financial performance that exceeded market expectations. The latest firm to signal its bullish outlook is Barclays, which has adjusted its forecast, raising the price…

Read More

When Illness Upends Retirement Plans

The vision of retirement is a golden one: travel, hobbies, family time, and finally taking a well-deserved rest. For too many Americans, however, this vision is shattered by a grim reality: the sudden or gradual onset of a serious illness. A health crisis doesn’t just impact your physical well-being; it can deliver a devastating financial…

Read More

Jim Cramer Still Calls CoreWeave’s Stock Price a “Win” Despite Being Significantly Down From Its Peak

Wall Street’s Wild Ride: Why Jim Cramer Still Calls CoreWeave a ‘Win’ Despite Massive Stock Slide If you have been watching the high-flying world of artificial intelligence stocks, you know the last few months have been less like a smooth flight and more like extreme turbulence. Few companies encapsulate this volatile market better than CoreWeave,…

Read More

Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result

A Biotech Story to Watch: Shattuck Labs Shines a Light on Inflammatory Disease Treatment Shattuck Labs, Inc. (STTK) is making headlines in the biotech world, and for good reason. The Austin and Durham based company recently delivered a stronger-than-expected quarterly financial report, but the real excitement is stemming from a critical development in its lead…

Read More